US › Healthcare

Conduit Pharmaceuticals Inc. (CDT)

US · Healthcare · Biotechnology

$0.19-4.29%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$750.2M

Revenue YoY

+11.6%

Net profit

$68.5M

EPS

$-8.71

Net margin

9.1%

Key statistics

Market cap

$3.4M

Forward P/E

0.0

P/B

0.03

Book value

$163.36

EPS (TTM)

$-3,050.69

52-week high

$236.00

52-week low

$0.23

50-day MA

$2.75

200-day MA

$133.47

Beta

1.45

Shareholding

Insiders

60.80%

Institutions

0.12%

Largest institutional holders

Fund	Stake
Financial Management Professionals Inc	0.16%
Tower Research Capital LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Apollon Wealth Management, LLC	0.00%
SBI Securities Co Ltd	0.00%
Virtu Financial LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Conduit Pharmaceuticals Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.